JOURNAL OF THROMBOSIS AND THROMBOLYSIS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2023-03-07 ms8078211981876019 来自北京

请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2022-07-08 ay

7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future.

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-12-13 锦鹤远云心

投稿命中率:25.0
经验分享：投过，秒拒。从稿号看命中率低于20％

113 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-05-21 1258f7b5m96暂无昵称

2.15初稿，4.30小修，5.16第二次小修，5.21接收

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-05-21 1258f7b5m96暂无昵称

谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表:
我的这个状态就一天

枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天

137 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-05-15 枫叶497

我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表:
你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗

182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗

90 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-05-11 1258f7b5m96暂无昵称

你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表:
4.1签版权转让，4.3收到proof，4.5online

枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online

120 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2020-03-27 枫叶497

2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月

107 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

118 0

[GetPortalCommentsPageByObjectIdResponse(id=2118143, encodeId=0fe92118143dd, content=请问杂志这个杂志under review是送外审了嘛？还是说编辑内审也是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35d91762719, createdName=ms8078211981876019, createdTime=Tue Mar 07 16:33:34 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1231284, encodeId=7491123128477, content=7.1投，7.3等待分配编辑，7.8拒。没有具体意见。Editor Comments: We very much appreciate your interest in THRO; the Journal receives many interesting submissions, but can only publish approximately 15% of them .The submitted work, although representing an interesting question and laudable effort was not felt to represent a high priority for publication. We wish the authors well in their academic endeavors and look forward to working together in the future. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c09e2145377, createdName=ay, createdTime=Fri Jul 08 10:10:27 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907485, encodeId=9d6c90e485dd, content=投稿命中率:25.0 经验分享：投过，秒拒。从稿号看命中率低于20％, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/b2c581d4929944e8a5ab31968445d451/87d38f57b09e4f95b63dec6381bf2c3b.jpg, createdBy=bab52364664, createdName=锦鹤远云心, createdTime=Sun Dec 13 05:11:43 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591434, encodeId=5e58591434db, content=2.15初稿，4.30小修，5.16第二次小修，5.21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591433, encodeId=5abb5914339a, content=谢谢，已经接受啦枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, beContent=枫叶 2020-05-15 00:00:00 发表: 我的这个状态就一天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590929, encodeId=c35559092983, content=我的这个状态就一天182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, beContent=182****1696暂无昵称 2020-05-11 00:00:00 发表: 你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590653, encodeId=a69a590653a8, content=你好，可以请问下，修稿提交后editor assignment pending这个状态需要多久吗枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, beContent=枫叶 2020-04-05 00:00:00 发表: 4.1签版权转让，4.3收到proof，4.5online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ec82574915, createdName=1258f7b5m96暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587531, encodeId=de9a58e531b2, content=2020.1.13投稿，3.9回来给12天时间大修，3.20提交修回稿，3.26接收。还是挺快的，投稿到接收2个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/29/f55cb8141fa3df744670d0238d0ebfe0.jpg, createdBy=48c62493460, createdName=枫叶497, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578632, encodeId=12185e863207, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548785, encodeId=171e548e8547, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffa51936247, createdName=liliping111, createdTime=Tue Oct 31 19:40:00 CST 2017, time=2017-10-31, status=1, ipAttribution=)]

2017-10-31 liliping111

审稿速度:3.0 | 投稿命中率:95.0
经验分享：2017.5.8投稿送审挺快，一审恰好三个月，因为之前还投了其他杂志耽误了时间，所以中途有发邮件问审稿情况，都是回复在审稿中，所以大家也别着急，一审可能就得三个月。2017.8.3 回来后是大修，没让补实验，两个审稿人，总共14条意见，都很中肯，修了一个月，9.3二审又等了一个月，10.8回来直接就接收了，还是蛮惊讶的，校样之后，10.14就first online了。而且只接受传统印刷，不选择OA的话，版面费是免费的，彩图也不收费，还是很良心的一本杂志。

206 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务